Ask ABBO
Login
Sign up

Evotec

Medicines
Halozyme Withdraws $2.1 Billion Acquisition Bid for Evotec

Halozyme Therapeutics (NASDAQ: HALO) has pulled its proposal to buy Evotec SE (NASDAQ: EVO) for 2 billion euros ($2.09 billion)

1 year ago

Evotec Receives €2 Billion Buyout Offer from Halozyme Therapeutics

On Thursday, Halozyme Therapeutics (NASDAQ: HALO) said it has proposed to buy German drug developer Evotec (NASDAQ: EVO) for about

1 year ago

Evotec (NASDAQ: EVO) Stock Surges After Triton Acquires Nearly 10% Stake, Mulls Buyout Bid

Shares in Evotec (NASDAQ: EVO) soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake

1 year ago

Novo Nordisk
Evotec and Novo Nordisk (NYSE: NVO) Form Technology Development Partnership for Stem Cell Therapies

Evotec (NASDAQ: EVO), the German drug and development company, has entered into a technology development partnership with Novo Nordisk (NYSE:

1 year ago